Note 7 - Goodwill and Intangible Assets (Details Textual) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Apr. 30, 2021 |
Apr. 30, 2020 |
Apr. 30, 2021 |
Apr. 30, 2020 |
|
Amortization of Intangible Assets, Total | $ 7,000 | $ 8,600 | $ 13,853 | $ 17,147 |
US Concrete Pumping [Member] | ||||
Reporting Unit, Percentage of Carrying Amount In Excess of Fair Value | 6.90% | 6.90% | ||
Goodwill, Impairment Loss | $ 38,500 | $ 43,500 | ||
UK Operations [Member] | ||||
Reporting Unit, Percentage of Carrying Amount In Excess of Fair Value | 14.80% | 14.80% | ||
Goodwill, Impairment Loss | $ 14,400 | $ 14,400 | ||
Brundage-Bone Concrete Pumping, Trade Name [Member] | ||||
Indefinite-lived Intangible Assets, Carrying Value in Excess of Fair Value, Percent | 11.80% | 11.80% | ||
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | $ 5,000 |
X | ||||||||||
- Definition Percentage of carrying value of intangible asset in excess of fair value. No definition available.
|
X | ||||||||||
- Definition Percentage of carrying amount of reporting unit in excess of fair value. No definition available.
|
X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|